US Pre-Market SEC Filings Roundup — March 17, 2026

16-03-2026

Dennis J. Wilson and affiliated Reporting Persons filed Amendment No. 15 to Schedule 13D on March 16, 2026, reporting no change in beneficial ownership of lululemon athletica inc. common stock since Amendment No. 14 filed March 9, 2026, with Wilson directly linked to 8.4% ownership and affiliates holding additional stakes totaling approximately 8-9% combined. On March 12, 2026, Wilson issued a press release containing a letter to potential CEO candidates criticizing the Board as unfit, calling for refreshment to support visionary leadership, and raising questions on independence, innovation investment, and internal talent development.

• ·Original Schedule 13D filed February 14, 2019
• ·House of Wilson Ltd., Laura Gentile, Eric Hirshberg, and Marc Maurer each report 0.0% ownership

17-03-2026

Carlisle Companies Inc (CSL) has filed DEFA14A additional proxy materials for its stockholder meeting on April 29, 2026, at 8:00 AM at The St. Regis Longboat Key Resort in Longboat Key, Florida. Key proposals include electing directors Sheryl D. Palmer and Jesse G. Singh, advisory approval of 2025 named executive officer compensation, and ratification of Deloitte & Touche LLP as the independent auditor for 2026, with the Board recommending FOR on all items. Shareholders can request free paper or email copies of materials by April 15, 2026, via www.ProxyVote.com, phone, or email.

• ·Materials request deadline: April 15, 2026
• ·Voting platform: www.ProxyVote.com or 1-800-579-1639
• ·Meeting address: 1601 Gulf of Mexico Drive, Longboat Key, Florida 34228

17-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) issued a press release on March 17, 2026, announcing that its RAD division received an order for 10 RIO Mini units with SARA licenses from a major Midwest construction company. No financial terms or order value were disclosed.

• ·Filing includes Exhibit 99.1: Press release dated March 17, 2026.

17-03-2026

BioCardia, Inc. announced on March 17, 2026, that the FDA has accepted its pre-submission package for approval of the Helix Transendocardial Delivery Catheter, intended for intramyocardial therapeutic and diagnostic agent delivery. This regulatory milestone advances the product's development pathway. No financial or performance metrics were disclosed.

• ·Filing includes Exhibit 99.1: BioCardia press release dated March 17, 2026
• ·Information furnished under Item 8.01, not deemed 'filed' under Section 18 of the Exchange Act

17-03-2026

A Paradise Acquisition Corp., a SPAC, is merging with Enhanced, an innovative sports company launching the Enhanced Games that permit FDA-approved performance-enhancing substances under medical supervision to prioritize athlete health, safety, and higher compensation compared to traditional athletics. CEO Max Martin discusses overcoming PED stigma, the Enhanced Games Medical Program run as a clinical study in Abu Dhabi with SSMC Hospital, and benefits for both elite and returning athletes. Accelerate Arbitrage Fund discloses a long position in A Paradise Acquisition shares and rights.

• ·Enhanced Games idea originated roughly 2.5 years ago.
• ·Athletes receive comprehensive baseline assessments and continuous medical screenings as part of the Medical Program.
• ·Focus on two athlete types: prime athletes aiming to break records and older athletes (e.g., mid-30s) seeking personal bests.

17-03-2026

Eureka Acquisition Corp, a SPAC, issued an interest-free $150,000 Extension Promissory Note to Marine Thinking Inc. on March 13, 2026, payable upon consummation of a business combination or the SPAC's term expiry. The note is convertible into private units at $10 per unit if elected prior to closing, with units non-transferable until business combination completion. This supports ongoing merger discussions ahead of a planned Form S-4 registration statement.

• ·Note filed as Exhibit 10.1 in Form 8-K dated March 16, 2026, effective March 17, 2026.
• ·Conversion requires notice at least two business days prior to business combination closing.
• ·Overdue amounts accrue interest at prevailing short-term US Treasury Bill rate.
• ·Annual Report on Form 10-K filed December 15, 2025.

17-03-2026

Mechanics Bancorp reported net income of $266M in 2025, up 817% YoY from $29M, boosted by a $145M bargain purchase gain from the September 2, 2025 merger with HomeStreet Bank and noninterest income swing to $223M from a $139M loss. Net interest income grew 13% YoY to $586M with NIM expanding 12 bps to 3.43%, while total assets expanded 36% to $22.4B and deposits rose 36% to $19.0B. However, provision for credit losses on loans increased to $20.5M from a $1.6M reversal, nonaccrual loans tripled to $43M (0.30% of total loans), and noninterest expenses rose 36% to $470M driven by $73M acquisition/integration costs.

• ·Common equity Tier 1 capital ratio for Mechanics Bancorp: 14.09% (newly reported post-merger)
• ·Tangible common equity ratio declined to 8.48% from 9.10%
• ·Loans to deposits ratio increased to 74.52% from 69.17%
• ·Full time equivalent employees grew 34% to 1,921

17-03-2026

ProCap Financial, Inc. (BRRWW) filed a DEFA14A Additional Proxy Statement on March 17, 2026. The provided content consists solely of standard forward-looking statement disclaimers, legal notices regarding securities offerings, and contact information for media and investors. No financial metrics, period-over-period comparisons, or material business updates are included.

17-03-2026

Cineverse Corp. filed a Form S-3 shelf registration statement on March 16, 2026, to register up to 21,805,701 shares of Class A Common Stock for resale by selling stockholders from time to time on Nasdaq or otherwise. The company will not receive any proceeds from these sales but has agreed to pay certain registration expenses to satisfy registration rights granted to the selling stockholders. The Common Stock (CNVS) had a last reported sale price of $2.60 per share on March 13, 2026.

• ·Registrant classified as non-accelerated filer and smaller reporting company.
• ·Incorporated in Delaware with I.R.S. Employer Identification Number 22-3720962.
• ·Principal executive offices at 224 W. 35th St., Suite 500, #947, New York, New York 10001.
• ·Par value of Common Stock: $0.001 per share.

17-03-2026

Pelican Acquisition Corp disclosed under Item 7.01 three promotional discussions on March 13, 14, and 16, 2026, featuring Greenland Energy Company's CEO Robert Price and incoming director Larry G. Swets, Jr., regarding the pending Business Combination with Greenland Exploration Limited, March GL, and PubCo. The filing furnishes transcripts as Exhibits 99.1 and 99.2 and references a Registration Statement on Form S-4 declared effective on February 17, 2026. It emphasizes forward-looking statements with extensive risk factors, including potential delays, redemptions, and failure to complete the merger.

• ·Registration Statement on Form S-4 effective February 17, 2026.
• ·Pelican 10-Q filings: July 31, 2025 (filed September 15, 2025), April 30, 2025 (filed June 27, 2025).
• ·S-1 effective May 22, 2025.

17-03-2026

For the six months ended January 31, 2026, PURE BIOSCIENCE, INC. reported revenue growth of 21.7% YoY to $1.152M, driven by strong performance in PURE Hard Surface (+46.8% to $1.136M for the month), while SILVÉRION revenue declined sharply 91.9% to $14,000. Net loss narrowed 16.0% YoY to $1.249M amid lower G&A expenses, however interest expense rose to $195,000 from $132,000 and dilutive securities outstanding surged 63.3% to 68.6M shares. Convertible notes increased to $5.52M principal plus $625,000 accrued interest.

• ·Fiscal 2026 Notes issued totaling $720K at 6.34%-6.68% interest, maturing Oct-Dec 2028.
• ·G&A expenses decreased 10.2% YoY to $1.498M for six months.
• ·Interest expense increased 47.7% YoY to $195K for six months.

17-03-2026

AmperCap Acquisition Company, a Cayman Islands blank check company incorporated on December 5, 2025, filed an S-1 registration statement for a $125M IPO (or $143.75M if over-allotment exercised) of units at $10.00 each, with proceeds primarily deposited into a trust account for a business combination within 24 months. The company has generated no revenues to date and highlights high investment risk with no Rule 419 protections. Underwriting discounts total $2.5M, with additional fees and working capital estimated at $4M.

• ·Incorporated December 5, 2025, as Cayman Islands exempted company.
• ·24-month completion window from IPO closing for business combination.
• ·Emerging growth company with reduced public reporting requirements.
• ·Units expected to list on NASDAQ as APMC and APMCW post-separate trading.

17-03-2026

Dragonfly Energy reported preliminary full year 2025 net sales of $58.6 million, up 15.8% YoY driven by 33.8% growth in OEM sales to $36.9 million, though DTC sales declined 8.5% to $20.7 million amid RV market softness. Q4 net sales increased 6.9% to $13.1 million with OEM up 30.1% to $8.1 million, but gross margin contracted to 18.2% from 20.8% and net loss widened to $45.0 million from $9.8 million. The company implemented a strategic cost realignment for $8.9 million in annualized savings and targets positive Adjusted EBITDA at a $70 million annual revenue run rate, while guiding Q1 2026 net sales at $9.5 million and Adjusted EBITDA loss of $4.6 million.

• ·Targets positive Adjusted EBITDA at $70M annual revenue run rate.
• ·Executive and Board cash compensation reduced 20% for remainder of FY2026, replaced with equity incentives.
• ·20% reduction in total payroll expense via workforce reductions and salary adjustments.
• ·Preliminary results subject to audit and potential material adjustments.
• ·Conference call held March 16, 2026 at 4:30 PM ET.

17-03-2026

Brookfield Infrastructure Corp's annual report for year ended December 31, 2025, reports cash from operating activities declining 8% YoY to $1,608M from $1,743M, while cash used in investing activities improved significantly with a reduced outflow of $612M from $1,110M. Cash used in financing activities worsened to $1,291M outflow from $428M. Non-recourse borrowings totaled $13.5B with projected interest expense of $4.95B, and base management fees grew 6% YoY to $71M.

• ·Exchangeable shares increased slightly to 132,994,956 as of Dec 31, 2025 from 132,051,909 in 2024 (+0.7%).
• ·USD stock highs in Q4 2025 reached $36.41, comparable to $36.42 in Q4 2024, with trading volume increasing to 36.2M units from 21.9M.

17-03-2026

Brookfield Infrastructure Partners L.P. reported strong FY2025 financials with revenues up 9.8% YoY to $23.1B, FFO up 6.4% to $2.6B, and net income attributable to the partnership surging 179% to $1.1B, driven by higher other income. However, mark-to-market losses widened to $548M from $26M, and in the Utilities segment, while total Adjusted EBITDA grew 6.1% to $1.3B, Regulated Transmission EBITDA was essentially flat at $552M (up 0.9%) after declining from $631M in 2023. The year featured active portfolio management with acquisitions totaling over $2B (e.g., HomeServe for $1.2B) and divestitures generating ~$1.5B in net proceeds.

• ·Total assets grew 22.5% to $128.2B as of Dec 31, 2025.
• ·Non-recourse borrowings increased to $59.6B from $46.6B.
• ·FFO payout ratio stable at 66% in 2025 vs 67% in 2024.
• ·Agreed sale of Mantiqueira expected to close H1 2026 for $150M.

17-03-2026

American Rebel Holdings Inc entered into a Securities Purchase Agreement issuing a promissory note to 1800 Diagonal Lending LLC with a principal amount of $124,200 purchased for $108,000 (including $16,200 OID), requiring total repayments of $147,487 over 15 monthly installments from April 15, 2026 to June 15, 2027 at an effective 15% interest rate. The note includes high default interest of 22%, acceleration to 150% of outstanding amounts upon events of default, and conversion rights into common stock (limited to 4.99% beneficial ownership, subject to Nasdaq 19.99% rule without stockholder approval), posing dilution risk. Prepayment is permitted at 95% of principal plus interest within the first 180 days without penalty.

• ·5-day grace period for payments; missed payment triggers Event of Default.
• ·Covenant restricts sale of significant assets without Holder consent to avoid shell company status.
• ·Events of Default include failure to pay (after 5 business days notice), covenant breaches (after 20 days notice), bankruptcy, delisting from Exchanges, non-compliance with Exchange Act reporting.
• ·Conversion rights exercisable only after Event of Default; Notice of Conversion must be before 6pm NY time.
• ·Prepayment requires 3 Trading Days prior notice; no partial prepayments except as specified.

17-03-2026

Cortigent, Inc. (CRGT), a spin-off from Vivani Medical, Inc., is filing Amendment No. 17 to its S-1 for a firm commitment IPO of 1,500,000 shares of common stock at an anticipated $10.00 per share, with an underwriter option for 225,000 additional shares; post-IPO, Vivani will own approximately 77% of voting power, making Cortigent a controlled company. The company develops investigational brain implant devices including the Orion Visual Prosthesis (targeting $4B US TAM for 82,000 profoundly blind Americans) and Stroke Recovery System ($6B annual US TAM amid 610,000 annual strokes), building on the discontinued Argus II system. As an emerging growth company with no established public market and high investment risks, including FDA approval uncertainties for its products, the offering highlights promising markets but pre-commercial status.

• ·Argus II sales discontinued in 2019 to refocus on Orion
• ·Orion completed 6-year Early Feasibility Study in March 2025 with FDA Breakthrough Device designation
• ·Applied for NYSE American listing under symbol CRGT; offering will not proceed without approval
• ·Emerging growth company and smaller reporting company status
• ·Investigational devices (Orion and Stroke Recovery) require FDA approval; no assurance of success

17-03-2026

Ethos Technologies Inc. reported revenue of $387.6M for FY 2025, up 52% YoY from $254.9M, driven by strong growth in DTC channel revenue (+40% to $242.5M) and third-party channel revenue (+79% to $145.1M). Gross profit rose 53% to $380.9M with margin expansion to 98% from 97%, and Adjusted EBITDA increased 55% to $89.0M with flat 23% margin; however, net income margin slightly declined to 18% from 19%, sales and marketing expenses surged 54% to $229.3M (59% of revenue), and G&A expenses jumped 77% to $39.6M (10% of revenue).

• ·Contribution profit FY 2025: $162.0M (42% margin) vs FY 2024: $104.6M (41% margin)
• ·Cost of revenue FY 2025: $6.7M vs FY 2024: $6.5M
• ·Depreciation and amortization FY 2025: $5.4M (flat YoY)
• ·Income tax expense FY 2025: $4.6M vs FY 2024: $5.1M

17-03-2026

Tenon Medical, Inc. closed a private placement of senior convertible promissory notes with institutional and high net worth investors for gross proceeds of $4.3 million before placement agent fees. The notes have a 20% original issue discount, aggregate principal of $4.3 million, mature on September 11, 2026, and are convertible into common stock after a six-month anniversary at 80% of the VWAP for the prior three trading days. Net proceeds will support commercial expansion, product development, clinical studies, working capital, and general corporate purposes.

• ·Notes not registered under Securities Act of 1933; may not be offered or sold absent registration or exemption
• ·WallachBeth Capital, Inc. acted as placement agent
• ·National launch of Catamaran SI Joint Fusion System in October 2022
• ·Company formed in 2012

17-03-2026

Two Harbors Investment Corp. (TWO) sent a solicitation letter to certain stockholders on March 16, 2026, urging them to vote in favor of its acquisition by UWM Holdings Corporation (UWMC) at the adjourned Special Meeting on March 24, 2026, at 11:00 a.m. ET, after unsuccessful prior contact attempts. The letter provides toll-free contact details for proxy solicitation and emphasizes the importance of stockholder response. While promoting the transaction, it cautions on forward-looking statements with significant risks, including potential failure to secure approvals, integration challenges, and adverse market effects.

• ·Registration Statement on Form S-4 declared effective by SEC on February 9, 2026; proxy statement/prospectus filed February 12, 2026.
• ·TWO 10-K for FY ended December 31, 2025 filed February 17, 2026.
• ·UWMC 10-K for FY ended December 31, 2025 filed February 25, 2026.

17-03-2026

On March 15, 2026, Sean Smith resigned as Chief Accounting Officer of QXO, Inc., effective immediately, to pursue employment closer to his family, and agreed to serve in an advisory role until June 30, 2026, with continued compensation including prorated salary, bonus, and equity vesting. The departure is not due to any disagreements on accounting principles, financial statements, or internal controls. On March 16, 2026, Robert Loughran was appointed as Interim Chief Accounting Officer, effective immediately, while the company searches for a permanent successor.

• ·No family relationships between Mr. Loughran and any directors or executive officers.
• ·No arrangements or understandings pursuant to which Mr. Loughran was selected as an officer.
• ·No material transactions involving Mr. Loughran subject to Item 404(a) of Regulation S-K.
• ·Mr. Loughran's prior roles: Partner at Elm Street Advisors (since 2023), CFO at Greenidge Generation Holdings (Jan 2022-Oct 2023), CAO at Greenidge (Jun 2021-Jan 2022), VP Corporate Controller at Tronox Holdings PLC (Apr 2018-Jun 2020), various senior roles at Avon including Group VP CAO (Mar 2016-Mar 2019) and VP Corporate Controller (May 2012-Mar 2016).
• ·Mr. Loughran is a Certified Public Accountant with a BS from University of Connecticut.

17-03-2026

Hammer Technology Holdings Corp. reported a reduced net loss from continuing operations of $153K for the three months ended January 31, 2026, compared to a $280K loss in the prior year period, driven by lower operating expenses ($139K vs. $348K). Cash and equivalents increased to $28K from $18K at July 31, 2025, supported by $339K in related-party financing, however total assets declined 22% to $182K amid amortization of intangibles, while total liabilities rose 19% to $1.15M and stockholders' deficit worsened to $(968K). For the six months, operating cash burn improved to $328K from $497K, but the company continues to generate no revenue from continuing operations.

• ·Intangible assets declined to $154K from $216K due to amortization.
• ·Selling, general and administrative expenses for six months ended Jan 31, 2026: $242K (down 33% YoY from $363K).
• ·No revenue reported from continuing operations in any period.
• ·Gain on disposal of subsidiaries in prior year discontinued operations: $1.66M for three and six months ended Jan 31, 2025.

17-03-2026

McEwen Inc. reported full-year 2025 revenue of $197.6 million, up 13% YoY from $174.5 million in 2024, driven by a 48% higher average realized price of $3,532 per GEO despite a 22% decline in GEO sales from 100% owned operations to 58,552. Consolidated GEO sales fell 16% to 113,732, including an 9% drop in attributable GEOs from the San José mine to 55,180. Additionally, on February 6, 2026, McEwen Copper secured a loan facility of up to $240 million, with $28.5 million drawn to date at 12% annual interest, to fund the Los Azules Project and other purposes.

• ·Loan proceeds for McEwen Copper to be used for general corporate purposes, working capital, going public transaction costs, and advancing Los Azules Project toward Final Investment Decision.
• ·Company received 203,280 transferable warrants to purchase McEwen Copper shares at $40 per share as part of loan agreement.
• ·Argentina corporate income tax rate changed to progressive 25%-35% for fiscal years starting on/after Jan 1, 2021, with annual inflation adjustments from Jan 2022.

17-03-2026

Xerox Holdings Corp reported total revenue of $7.0B for the year ended December 31, 2025, up 12.9% YoY from $6.2B in 2024, driven by IT Solutions revenue surging 112.6% to $761M and post-sale revenue growing 14.3% to $5.5B. However, Print and Other segment profit declined 29.5% to $279M from $396M, total segment profit fell 18.9% to $321M, adjusted operating profit dropped 17.9% to $248M, and total gross margin compressed 4.4 percentage points to 27.1%. Pre-tax loss narrowed to $488M from $1.2B but remained negative amid higher expenses.

• ·Equipment gross margin declined to 21.4% in 2025 from 30.2% in 2024 (-8.8 pts)
• ·Post sale gross margin declined to 28.6% in 2025 from 31.9% in 2024 (-3.3 pts)
• ·SAG as % of revenue improved slightly to 23.6% in 2025 from 24.7% in 2024 (+1.1 pts)
• ·Non-financing interest expense rose to $248M in 2025 from $119M in 2024
• ·Other expenses, net increased to $360M in 2025 from $158M in 2024

17-03-2026

BW Industrial Holdings Inc., a Delaware-based general building contractor for nonresidential buildings, filed Amendment No. 2 to its S-1 registration statement on March 17, 2026, for an IPO of 2,625,000 shares of common stock on NYSE American under symbol BWGC, with an anticipated price range of $6-$7 per share (midpoint $6.50), targeting gross proceeds of $17.1M. Net proceeds to the company before expenses are estimated at $16.0M after 6% underwriting discounts of $1.0M to lead underwriter Eddid Securities USA Inc., with a 45-day over-allotment option for up to 393,750 additional shares potentially increasing totals to $19.6M gross and $18.4M net. Post-IPO, CEO and Director Yunlong Zhang will retain control with approximately 57.21% voting power, qualifying the company as a 'controlled company' and emerging growth company.

• ·Company address: 2825 Wilcrest Drive, Suite 421, Houston, TX 77042.
• ·I.R.S. Employer Identification No.: 33-4856491.
• ·Standard Industrial Classification Code: 1541 (General Building Contractors - Nonresidential Buildings).
• ·SEC File Number: 333-292504.
• ·Emerging growth company electing reduced reporting requirements under JOBS Act.

17-03-2026

On March 13, 2026, First Industrial Realty Trust, Inc.'s Board of Directors increased its size from six to seven members and elected Frank E. Schmitz as a new director effective June 1, 2026, until the 2027 annual meeting. The Board also approved a new stock repurchase program authorizing up to $250M of common stock purchases, with no specified expiration date and flexibility in execution methods compliant with federal securities laws. A press release was issued on March 16, 2026, regarding these developments amid ongoing proxy solicitation for the 2026 Annual Meeting.

• ·No arrangement or understanding pursuant to which Mr. Schmitz was elected; no related party transactions under Item 404(a) of Regulation S-K.
• ·Repurchase Program may be modified, suspended, or terminated at Board's discretion; open market repurchases to comply with Rule 10b-18.
• ·Preliminary proxy statement filed February 27, 2026, for 2026 Annual Meeting with ongoing solicitation using WHITE proxy card.